Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data
利用IORRA真实世界数据评估阿巴西普作为日本类风湿性关节炎患者一线治疗方案的成本效益
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0277566
Tanaka, Eiichi; Inoue, Eisuke; Shoji, Ayako; Nilsson, Jonas; Papagiannopoulos, Christos; Dhanda, Devender; Yoshizawa, Yuri; Abe, Mai; Saka, Kumiko; Sugano, Eri; Sugitani, Naohiro; Ochiai, Moeko; Yamaguchi, Rei; Ikari, Katsunori; Yamanaka, Hisashi; Harigai, Masayoshi